These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6720461)

  • 61. Effects of a new glucocorticoid, deflazacort, on pituitary-adrenal function in man: a comparison with prednisone.
    Criscuolo D; Fraioli F; Bonifacio V; Paolucci D; Isidori A
    Int J Clin Pharmacol Ther Toxicol; 1980 Jan; 18(1):37-41. PubMed ID: 6245036
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effects of glucocorticoids on bone cell metabolism and function.
    Peck WA
    Adv Exp Med Biol; 1984; 171():111-9. PubMed ID: 6372390
    [No Abstract]   [Full Text] [Related]  

  • 63. Effects of chronic corticosteroid therapy on mineral metabolism and calcium absorption.
    Avioli LV
    Adv Exp Med Biol; 1984; 171():81-9. PubMed ID: 6372405
    [No Abstract]   [Full Text] [Related]  

  • 64. [Cortisone-induced osteoporosis: from physiopathogenesis to treatment].
    Peretz A
    Rev Med Brux; 1991 Oct; 12(8):321-8. PubMed ID: 1947526
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Problems in evaluating dose equivalences of glucocorticoids.
    Köbberling J; Rotenberger J
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):434-6. PubMed ID: 1490770
    [No Abstract]   [Full Text] [Related]  

  • 66. How to prevent glucocorticoid-induced osteoporosis.
    Dore RK
    Cleve Clin J Med; 2010 Aug; 77(8):529-36. PubMed ID: 20682515
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Methods for reducing undesirable side effects of glucocorticoids.
    Hahn BH; Hahn TJ
    Adv Exp Med Biol; 1984; 171():301-11. PubMed ID: 6720461
    [No Abstract]   [Full Text] [Related]  

  • 68. Adverse effects of corticosteroids on bone metabolism: a review.
    Mitra R
    PM R; 2011 May; 3(5):466-71; quiz 471. PubMed ID: 21570035
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Glucocorticoids, glucose metabolism and hypothalamic-pituitary-adrenal axis.
    Wajchenberg BL; Prestes Cesar F; Okada H; Torres de Toledo e Souza I; Lerário AC; Borghi VC; Malerbi DA; Giurna Filho A; Liberman B; Gianella D
    Adv Exp Med Biol; 1984; 171():25-44. PubMed ID: 6372395
    [No Abstract]   [Full Text] [Related]  

  • 70. [Glucocorticoids and risk of osteoporosis. On the problem of equivalent dose of desirable and undesirable effects of various glucocorticoids, exemplified by deflazacort].
    Rotenberger J; Köbberling J
    Med Klin (Munich); 1993 Jul; 88(7):432-7. PubMed ID: 8377721
    [No Abstract]   [Full Text] [Related]  

  • 71. Glucocorticoid-induced osteoporosis: an update.
    Mazziotti G; Angeli A; Bilezikian JP; Canalis E; Giustina A
    Trends Endocrinol Metab; 2006; 17(4):144-9. PubMed ID: 16678739
    [TBL] [Abstract][Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.